Automated identification and quantification of subretinal fibrosis in neovascular age-related macular degeneration using polarization-sensitive OCT

Investigative Ophthalmology and Visual Science

Volumn 57, Issue 4, 2016, Pages 1699-1705

  Roberts, Philipp ^a   Sugita, Mitsuro ^b,c   DeáK, Gábor ^a   Baumann, Bernhard ^b   Zotter, Stefan ^b   Pircher, Michael ^b   Sacu, Stefan ^a   Hitzenberger, Christoph K ^b   Schmidt Erfurth, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Christian Doppler Laboratory for Innovative Optical Imaging and its Translation to Medicine   (Austria)

^c CANON INC   (Japan)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Fibrosis; Polarization sensitive optical coherence tomography; Subretinal hyperreflective tissue

Indexed keywords

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; AUTOREFRACTOR; BIOMEDICAL ENGINEERING; CLINICAL ARTICLE; COMPARATIVE STUDY; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; POLARIZATION; PRIORITY JOURNAL; RELIABILITY; SIGNAL NOISE RATIO; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; COMPLICATION; DEVICES; EQUIPMENT DESIGN; FIBROSIS; IMAGE PROCESSING; MACULAR DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; RETINA NEOVASCULARIZATION; RETINAL PIGMENT EPITHELIUM;

AGED; EQUIPMENT DESIGN; FEMALE; FIBROSIS; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MACULAR DEGENERATION; MALE; REPRODUCIBILITY OF RESULTS; RETINAL NEOVASCULARIZATION; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84976869164     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-18694     Document Type: Article

References (38)

1. Schmidt-Erfurth U, Chong V, Loewenstein A, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014;98:1144-1167.
2. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of agerelated macular degeneration in the United States. Arch Ophthalmol. 2004;122:564-572.
3. Gemmy Cheung CM, Li X, Cheng CY, et al. Prevalence and risk factors for age-related macular degeneration in Indians: a comparative study in Singapore and India. Am J Ophthalmol. 2013;155:764-773.
4. Kawasaki R, Yasuda M, Song SJ, et al. The prevalence of agerelated macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology. 2010;117:921-927.
5. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108:697-704.
6. Daniel E, Toth CA, Grunwald JE, et al. Risk of scar in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2014;121:656-666.
7. Bloch SB, Lund-Andersen H, Sander B, Larsen M. Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab. Am J Ophthalmol. 2013;156:116-124. e1.
8. Toth LA, Stevenson M, Chakravarthy U. Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: outcomes in eyes with poor initial vision. Retina. 2015;35:1957-1963.
9. Schmidt-Erfurth U, Waldstein SM. A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration. Prog Retin Eye Res. 2015;50:1-24.
10. Wojtkowski M, Leitgeb R, Kowalczyk A, Bajraszewski T, Fercher AF. In vivo human retinal imaging by Fourier domain optical coherence tomography. J Biomed Opt. 2002;7:457-463.
11. Willoughby AS, Ying GS, Toth CA, et al. Subretinal hyperreflective material in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2015;122: 1846-1853.e5.
12. Ying GS, Kim BJ, Maguire MG, et al. Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials. JAMA Ophthalmol. 2014;132:915-921.
13. Keane PA, Patel PJ, Liakopoulos S, Heussen FM, Sadda SR, Tufail A. Evaluation of age-related macular degeneration with optical coherence tomography. Surv Ophthalmol. 2012;57: 389-414.
14. Shah VP, Shah SA, Mrejen S, Freund KB. Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration. Retina. 2014;34:1281-1288.
15. Pircher M, Hitzenberger CK, Schmidt-Erfurth U. Polarization sensitive optical coherence tomography in the human eye. Prog Retin Eye Res. 2011;30:431-451.
16. Cense B, Wang Q, Lee S, et al. Henle fiber layer phase retardation measured with polarization-sensitive optical coherence tomography. Biomed Opt Express. 2013;4:2296-2306.
17. Baumann B, Baumann SO, Konegger T, et al. Polarization sensitive optical coherence tomography of melanin provides intrinsic contrast based on depolarization. Biomed Opt Express. 2012;3:1670-1683.
18. Baumann B, Gotzinger E, Pircher M, et al. Segmentation and quantification of retinal lesions in age-related macular degeneration using polarization-sensitive optical coherence tomography. J Biomed Opt. 2010;15:061704.
19. Zotter S, Pircher M, Gotzinger E, et al. Measuring retinal nerve fiber layer birefringence, retardation, and thickness using wide-field, high-speed polarization sensitive spectral domain OCT. Invest Ophthalmol Vis Sci. 2013;54:72-84.
20. Pierce MC, Strasswimmer J, Park BH, Cense B, de Boer JF. Advances in optical coherence tomography imaging for dermatology. J Invest Dermatol. 2004;123:458-463.
21. Babalola O, Mamalis A, Lev-Tov H, Jagdeo J. Optical coherence tomography (OCT) of collagen in normal skin and skin fibrosis. Arch Dermatol Res. 2014;306:1-9.
22. Miura M, Yamanari M, Iwasaki T, et al. Imaging polarimetry in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:2661-2667.
23. Michels S, Pircher M, Geitzenauer W, et al. Value of polarisation-sensitive optical coherence tomography in diseases affecting the retinal pigment epithelium. Br J Ophthalmol. 2008;92:204-209.
24. Hong YJ, Miura M, Ju MJ, Makita S, Iwasaki T, Yasuno Y. Simultaneous investigation of vascular and retinal pigment epithelial pathologies of exudative macular diseases by multifunctional optical coherence tomography. Invest Ophthalmol Vis Sci. 2014;55:5016-5031.
25. Liegl R, Koenig S, Siedlecki J, Haritoglou C, Kampik A, Kernt M. Temsirolimus inhibits proliferation and migration in retinal pigment epithelial and endothelial cells via mTOR inhibition and decreases VEGF and PDGF expression. PLoS One. 2014;9: e88203.
26. Jaffe GJ, Eliott D, Wells JA, Prenner JL, Papp A, Patel SA. A phase 1 study of intravitreous E10030 in combination with ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2016;123:78-85.
27. Sugita M, Zotter S, Pircher M, et al. Motion artifact and speckle noise reduction in polarization sensitive optical coherence tomography by retinal tracking. Biomed Opt Express. 2013;5: 106-122.
28. Gotzinger E, Pircher M, Hitzenberger CK. High speed spectral domain polarization sensitive optical coherence tomography of the human retina. Opt Express. 2005;13:10217-10229.
29. Pircher M, Gotzinger E, Baumann B, Hitzenberger CK. Corneal birefringence compensation for polarization sensitive optical coherence tomography of the human retina. J Biomed Opt. 2007;12:041210.
30. Gotzinger E, Pircher M, Geitzenauer W, et al. Retinal pigment epithelium segmentation by polarization sensitive optical coherence tomography. Opt Express. 2008;16:16410-16422.
31. Ahlers C, Gotzinger E, Pircher M, et al. Imaging of the retinal pigment epithelium in age-related macular degeneration using polarization-sensitive optical coherence tomography. Invest Ophthalmol Vis Sci. 2010;51:2149-2157.
32. Lammer J, Bolz M, Baumann B, et al. Imaging retinal pigment epithelial proliferation secondary to PASCAL photocoagulation in vivo by polarization-sensitive optical coherence tomography. Am J Ophthalmol. 2013;155:1058-1067.e1
33. Sayegh RG, Zotter S, Roberts PK, et al. Polarization-sensitive optical coherence tomography and conventional retinal imaging strategies in assessing foveal integrity in geographic atrophy. Invest Ophthalmol Vis Sci. 2015;56:5246-5255.
34. Schlanitz FG, Sacu S, Baumann B, et al. Identification of drusen characteristics in age-related macular degeneration by polarization-sensitive optical coherence tomography. Am J Ophthalmol. 2015;160:335-344.e1.
35. Schutze C, Wedl M, Baumann B, Pircher M, Hitzenberger CK, Schmidt-Erfurth U. Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration. Am J Ophthalmol. 2015;159:1100-1114.
36. Zotter S, Pircher M, Torzicky T, et al. Large-field high-speed polarization sensitive spectral domain OCTand its applications in ophthalmology. Biomed Opt Express. 2012;3:2720-2732.
37. Gotzinger E, Pircher M, Baumann B, et al. Speckle noise reduction in high speed polarization sensitive spectral domain optical coherence tomography. Opt Express. 2011;19:14568-14585.
38. Grunwald JE, Daniel E, Huang J, et al. Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmol. 2014;121:150-161.